MedPath

The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life

Conditions
Bladder Cancer
Registration Number
NCT05195515
Lead Sponsor
Aarhus University Hospital
Brief Summary

Bladder Cancer prognosis, treatment, and subsequent morbidity and mortality vary between the different stages, thus resulting in a different impact on patients' lives. There are some well known late effects of the treatments for bladder cancer, but the knowledge of their impact on patients Quality of Life is sparse. This study aims to determine the prevalence of late effects impact on Quality of Life and potential risk factors for impairment.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
2000
Inclusion Criteria
  • Patients are eligible if they are referred to a hospital in the Central Region Denmark, due to hematuria between 01/01/2022 and 01/01/2023
  • Ability to understand written and oral Danish
Exclusion Criteria
  • Known Alzheimers disease
  • Diagnosed other causes explaining the hematuria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Health-related Quality of Life5 years from baseline inclusion

Changes in Quality of Life measured using validated instruments

Secondary Outcome Measures
NameTimeMethod
Prevalence of late effects5 years from baseline inclusion

Based on Patient Reported Outcomes and medical records

Trial Locations

Locations (5)

Department of Urology, Aarhus University Hospital

🇩🇰

Aarhus N, Denmark

Department of Urology, Regional Hospital Gødstrup

🇩🇰

Gødstrup, Denmark

Department of Urology, Regional Hospital Horsens

🇩🇰

Horsens, Denmark

Department of Urology, Regional Hospital Randers

🇩🇰

Randers, Denmark

Department of Urology, Regional Hospital Viborg

🇩🇰

Viborg, Denmark

Department of Urology, Aarhus University Hospital
🇩🇰Aarhus N, Denmark
© Copyright 2025. All Rights Reserved by MedPath